[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-366601-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-366601-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","machine-learning-assisted-analysis-of-patient-clinical-biomarkers-to-improve-ovarian-cancer-diagnosis","Machine-Learning-Assisted Analysis of Patient Clinical Biomarkers to Improve Ovarian Cancer Diagnosis","","Accurate early detection remains a major gap in ovarian cancer diagnosis and management. Integrating machine learning with biomarker-based blood testing offers a route to improve sensitivity and selectivity. This study analyzes clinically relevant datasets from more than 300 patients with ovarian tumors and 47 blood-derived features to separate cancerous from benign cases. Key discriminators include HE4, CA125, menopausal status, and age, with age showing strong discriminatory power mainly in premenopausal patients. The work emphasizes considering menopausal status, algorithm types, and feature set size to strengthen screening accuracy. Overall, it advances quantitative feature selection approaches for better diagnostic outcomes.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/machine-learning-assisted-analysis-of-patient-clinical-biomarkers-to-improve-ovarian-cancer-diagnosis/366601/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/machine-learning-assisted-analysis-of-patient-clinical-biomarkers-to-improve-ovarian-cancer-diagnosis/366601.png","ImageObject",300,407,{"name":42,"@type":43},"Aldword","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What gap does the study target in ovarian cancer diagnosis?","Question",{"text":63,"@type":64},"The study addresses the lack of accurate and reliable methods for early ovarian cancer detection, which is a major gap in diagnosis and management.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which patient blood-derived features were found to be most important?",{"text":68,"@type":64},"HE4, CA125, menopausal status, and age were identified as some of the most important features distinguishing cancerous from benign tumors across patient populations.",{"name":70,"@type":61,"acceptedAnswer":71},"How does menopausal status affect the value of age in classification?",{"text":72,"@type":64},"Age showed critical discriminatory power in premenopausal patients, while it was less influential in postmenopausal patients.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},366601,1790898090,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336478940917,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","ACS Partner Journal  \nThis article is licensed under CC-BY-NC-ND 4.0  \n[pubs.acs.org/PrecisionChem](pubs.acs.org/PrecisionChem)  Article   \nMachine-Learning-Assisted Analysis of Patient Clinical Biomarkers to Improve Ovarian Cancer Diagnosis  \nPublished as part of Precision Chemistry special issue “Precision Diagnostics”.  \nCélia Sahli, Tiffany Thanhtruc Pham, and Kenry*  \n Cite This: Precis. Chem. 2025, 3, 554−566  \nRead Online  \n\n|  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- |\n| ACCESS   | Metrics & More |  |  Article Recommendations |  | *sı Supporting Information |\n\nABSTRACT: The unavailability of accurate and reliable methods for early ovarian cancer detection represents a major gap in ovarian cancer diagnosis and management. The emergence and recent integration of machine learning with cancer diagnostic techniques, particularly biomarker-based blood tests, have the potential to improve the selectivity and sensitivity of ovarian cancer detection substantially. Herein, we leverage a series of machine learning and statistical approaches to analyze clinically relevant data sets of more than 300 patients with ovarian tumors and 47 blood-obtained features to distinguish between cancerous and benign tumors. We found that HE4, CA125, menopausal status, and age were some of the most important features distinguishing cancerous from benign ovarian tumors in all patient populations. Age was noted to be a critical feature with cancer discriminatory power only in premenopausal patients but less so in postmenopausal patients. Systematic consideration of patient menopausal status, types of machine learning algorithms, and number of clinical features is necessary prior to ovarian cancer screening to yield more accurate and reliable diagnostic results. Overall, this study provides deeper insight into the use of machine learning, feature selection, and other relevant quantitative approaches to advance ovarian cancer diagnosis to improve patient outcomes.  \nKEYWORDS: ovarian cancer, clinical biomarkers, menopause, machine learning, precision diagnostics.  \n■ INTRODUCTION  \nOvarian cancer is one of the most lethal gynecological cancers with a five-year survival rate below 50%.1 Most of the ovarian cancer cases are typically diagnosed at later stages when the primary tumors have spread beyond the peritoneal cavity.2−4 If detected earlier when the tumors are still confined within the ovaries, the five-year survival rate of ovarian cancer patients can be higher than 90%.1 As a complex disease, the onset of ovarian cancer is influenced by various factors, including age and menopausal status.5−7 As women age and experience menopausal transition, their ovaries may undergo physiological changes, which may then influence the production of essential hormones such as estrogen. This hormonal shift has been reported to contribute to the pathogenesis of ovarian cancer.8,9 Current ovarian cancer diagnostic methods include pelvic examination, imaging tests like transvaginal ultrasound (TVUS) and magnetic resonance imaging (MRI), and blood tests detecting the presence of common ovarian cancer biomarkers like cancer antigen 125 (CA125), CA19−9, carcinoembryonic antigen (CEA), human epididymis protein 4 (HE4), and α fetoprotein (AFP). 10−14 Pelvic examination, asa routine part of gynecological check-ups, is used to detect ovarian tumors, but this method lacks specificity in differ-  \nentiating between benign and cancerous tumors.15, 16 Nonspecific findings such as pelvic masses can also be due to other conditions like cysts or fibroids. Furthermore, pelvic examination may miss early-stage tumors due to its limited sensitivity. While TVUS allows for the visualization of the ovaries and can identify abnormalities such as cysts or masses, it cannot definitively determine whether these abnormalities are benign or cancerous.17, 18 Similarly, MRI can provide detailed images of the ovaries and the surrounding tissues, but it may not be able to reliably ass","cbCaitxzf4krFxOj","https://ap.wps.com/l/cbCaitxzf4krFxOj","pdf",7066162,13,"English","# Introduction\n## Clinical problem and diagnostic limitations\n# Methods\n## Data preprocessing and feature scoring\n## Statistical feature selection\n## Machine learning training and evaluation\n# Results\n## Key discriminative biomarkers\n## Effect of menopausal status on feature importance\n# Discussion\n## Implications for ovarian cancer screening\n# Conclusion\n## Quantitative approach to improve diagnostic outcomes","[{\"question\":\"What gap does the study target in ovarian cancer diagnosis?\",\"answer\":\"The study addresses the lack of accurate and reliable methods for early ovarian cancer detection, which is a major gap in diagnosis and management.\"},{\"question\":\"Which patient blood-derived features were found to be most important?\",\"answer\":\"HE4, CA125, menopausal status, and age were identified as some of the most important features distinguishing cancerous from benign tumors across patient populations.\"},{\"question\":\"How does menopausal status affect the value of age in classification?\",\"answer\":\"Age showed critical discriminatory power in premenopausal patients, while it was less influential in postmenopausal patients.\"}]","Machine-Learning-Assisted Analysis of Patient Clinical Biomarkers to Improve Ovarian Cancer Diagnosis | PDF",1790166380,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8033ba9626c82d8fb07f55ab2a7549c7.webp",983,1296,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f2d6068ef72b68d865e574f2f12fb2c5.webp",982,1295,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/35d041aa830a811cccd3a14527e177c7.webp",981,1293,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e77205d53ce321f5724b1902714b2583.webp",980,1292]